SEC Form 4 · accession 0001209191-15-000927
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Judith Ogrady
Officer — CorpVP,Reg.Affairs,CorpCompli
Period of report
Jan 2, 2015
Accepted (ET)
Jan 5, 2015 · 4:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000917520
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 2, 2015 | S | 3,000 | $53.1853 | D | 7,706 | D | |
| Common StockF3 | Jan 2, 2015 | S | 500 | $54.1721 | D | 7,206 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- F2The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $53.00 to $53.43.
- F3The price shown above represents the weighted average price of the shares sold. The range of sale prices was $54.0650 to $54.21.